You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

gefitinib

Showing 1 - 25 of 197
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor Trial in Seoul (Gefitinib)

Completed
  • Solid Tumor
  • Gefitinib
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

Lung Cancer Trial in Boston (EGF816, Gefitinib)

Active, not recruiting
  • Lung Cancer
  • Boston, Massachusetts
    Massachusetts General Hospital
Jan 21, 2022

Ovarian Cancer, Peritoneal Tumors, Fallopian Tube Cancer Trial in Houston (Topotecan, Gefitinib)

Completed
Has Results
  • Ovarian Cancer
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 11, 2022

NSCLC Trial in Japan, Korea, Republic of, United States (Gefitinib, MEDI4736)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Tampa, Florida
  • +6 more
Mar 22, 2022

NSCLC Trial in Singapore (Gefitinib)

Completed
  • Non-small Cell Lung Cancer
  • Gefitinib
  • Singapore, Singapore
    National Cancer Centre
May 31, 2021

Cancer Medicines in Metastatic Non-small Cell Lung Cancer in

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Oslo, Norway
    Pfizer Norway
Apr 17, 2023

NSCLC With EGFR-Activating Mutations Trial in Worldwide (Dacomitinib (PF-00299804), Gefitinib)

Completed
Has Results
  • Non-small Cell Lung Cancer With EGFR-Activating Mutations
  • Dacomitinib (PF-00299804)
  • Gefitinib
  • Beijing, China
  • +51 more
Feb 10, 2022

Non Small Cell Lung Cancer Trial in Beijing (HS-10296, Gefitinib)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Beijing, China
    Beijing Cancer Hospital
Jan 19, 2022

NSCLC Trial in Worldwide (Tepotinib, Gefitinib, Pemetrexed)

Completed
Has Results
  • Non-small Cell Lung Cancer
  • Beijing, China
  • +43 more
Oct 13, 2022

EGFR-mutant NSCLC Trial in Worldwide (EGF816, trametinib, ribociclib)

Active, not recruiting
  • EGFR-mutant Non-small Cell Lung Cancer
  • Toronto, Ontario, Canada
  • +10 more
Dec 5, 2022

Non-small Cell Lung Carcinoma Trial (Pembrolizumab, Paclitaxel, Carboplatin)

Completed
Has Results
  • Non-small Cell Lung Carcinoma
  • Pembrolizumab
  • +7 more
  • (no location specified)
Oct 13, 2022

Rare Tumor, Refractory Tumor Trial in Shanghai (Gefitinib, Erlotinib, Afatinib)

Recruiting
  • Rare Tumor
  • Refractory Tumor
  • Gefitinib
  • +11 more
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Feb 16, 2022

Advanced NSCLC With EGFR Mutation Trial in Zhengzhou (S-1 plus Gefitinib, Gefitinib)

Unknown status
  • Advanced NSCLC With EGFR Mutation
  • S-1 plus Gefitinib
  • Gefitinib
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Jul 8, 2020

Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma Trial in Philadelphia (drug, radiation, other)

Completed
  • Adult Giant Cell Glioblastoma
  • +2 more
  • gefitinib
  • +2 more
  • Philadelphia, Pennsylvania
    Radiation Therapy Oncology Group
Oct 29, 2020

PFS Trial in Shanghai (Gefitinib, Bevacizumab Combined With Gefitinib)

Recruiting
  • PFS
  • Gefitinib
  • Bevacizumab Combined With Gefitinib
  • Shanghai, Shanghai, China
    Cancer hospital Fudan University
Jun 10, 2020

Advanced Solid Tumors Which Are cMET-dependent Trial in Worldwide (Capmatinib, Nazartinib, Gefitinib)

Recruiting
  • Advanced Solid Tumors Which Are cMET-dependent
  • Boston, Massachusetts
  • +12 more
Jan 27, 2023

NSCLC Trial in Worldwide (INC280, Gefitinib)

Completed
Has Results
  • Non-small Cell Lung Cancer
  • Woolloongabba, Queensland, Australia
  • +30 more
Mar 12, 2021

NSCLC, EGFR Gene Mutation Trial in Nanchang (Gefitinib, Anlotinib)

Unknown status
  • Non-small Cell Lung Cancer
  • EGFR Gene Mutation
  • Nanchang, Jiangxi, China
    The Second Afiliated Hospital of Nanchang University
Apr 21, 2020

Non Small Cell Lung Cancer Trial in Japan (DS-1205c, Gefitinib)

Completed
  • Non Small Cell Lung Cancer
  • Chikusa, Aichi, Japan
  • +7 more
Jul 3, 2020

NSCLC Trial in Guangzhou (Volitinib, gefitinib)

Completed
  • Non-Small Cell Lung Cancer
  • Guangzhou, China
    Guangdong General Hospital
Apr 20, 2020

Non Small Cell Lung Cancer Trial in Nanjing (Gefitinib)

Completed
  • Non Small Cell Lung Cancer
  • Gefitinib
  • Nanjing, Jiangsu, China
    Nanjing General Hospital of Nanjing Military Command
Feb 5, 2020

Bevacizumab Plus EGFR-TKIs in Chinese EGFR-mutant

Recruiting
  • NSCLC
  • Guangzhou, Guangdong, China
    Guangdong Provincial People's Hospital
Oct 17, 2020

NSCLC Trial (SH-1028 tablets, Placebo SH-1028 tablets, Gefitinib)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • SH-1028 tablets
  • +3 more
  • (no location specified)
Jan 20, 2020

Bladder Cancer Trial in Canada (biological, drug, procedure)

Terminated
  • Bladder Cancer
  • BCG vaccine
  • +2 more
  • Vancouver, British Columbia, Canada
  • +5 more
Apr 1, 2020

NSCLC Trial in Shanghai, Hangzhou (Fruquintinib, Gefitinib)

Completed
  • NSCLC
  • Shanghai, Shanghai, China
  • +1 more
Nov 14, 2019